177 related articles for article (PubMed ID: 15185313)
1. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.
Major ME; Dahari H; Mihalik K; Puig M; Rice CM; Neumann AU; Feinstone SM
Hepatology; 2004 Jun; 39(6):1709-20. PubMed ID: 15185313
[TBL] [Abstract][Full Text] [Related]
2. Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase.
Watanabe H; Wells F; Major ME
J Viral Hepat; 2010 Apr; 17(4):245-53. PubMed ID: 19709361
[TBL] [Abstract][Full Text] [Related]
3. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.
Puig M; Mihalik K; Tilton JC; Williams O; Merchlinsky M; Connors M; Feinstone SM; Major ME
Hepatology; 2006 Sep; 44(3):736-45. PubMed ID: 16941702
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections.
Prince AM; Pawlotsky JM; Soulier A; Tobler L; Brotman B; Pfahler W; Lee DH; Li L; Shata MT
J Viral Hepat; 2004 May; 11(3):236-42. PubMed ID: 15117325
[TBL] [Abstract][Full Text] [Related]
5. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection.
Puig M; Major ME; Mihalik K; Feinstone SM
Vaccine; 2004 Feb; 22(8):991-1000. PubMed ID: 15161076
[TBL] [Abstract][Full Text] [Related]
6. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.
Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE
Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.
Aberle JH; Formann E; Steindl-Munda P; Weseslindtner L; Gurguta C; Perstinger G; Grilnberger E; Laferl H; Dienes HP; Popow-Kraupp T; Ferenci P; Holzmann H
J Clin Virol; 2006 May; 36(1):24-31. PubMed ID: 16483838
[TBL] [Abstract][Full Text] [Related]
8. Acute/recent HCV infection. Clinical course, viral replication kunetic and disease outcome.
Tsertsvadze T; Sharvadze L; Dzigua L; Dolmazashvili E; Nelson KE
Georgian Med News; 2008 Dec; (165):43-9. PubMed ID: 19124916
[TBL] [Abstract][Full Text] [Related]
9. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees.
Bassett SE; Di Bisceglie AM; Bacon BR; Sharp RM; Govindarajan S; Hubbard GB; Brasky KM; Lanford RE
Hepatology; 1999 Jun; 29(6):1884-92. PubMed ID: 10347134
[TBL] [Abstract][Full Text] [Related]
10. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.
Major ME; Mihalik K; Puig M; Rehermann B; Nascimbeni M; Rice CM; Feinstone SM
J Virol; 2002 Jul; 76(13):6586-95. PubMed ID: 12050371
[TBL] [Abstract][Full Text] [Related]
11. Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee.
Youn JW; Park SH; Lavillette D; Cosset FL; Yang SH; Lee CG; Jin HT; Kim CM; Shata MT; Lee DH; Pfahler W; Prince AM; Sung YC
Hepatology; 2005 Dec; 42(6):1429-36. PubMed ID: 16317673
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
14. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
15. Early dynamics of hepatitis C virus in the circulation of chimpanzees with experimental infection.
Tanaka J; Katayama K; Kumagai J; Komiya Y; Yugi H; Kishimoto S; Mizui M; Tomoguri T; Miyakawa Y; Yoshizawa H
Intervirology; 2005; 48(2-3):120-3. PubMed ID: 15812184
[TBL] [Abstract][Full Text] [Related]
16. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
Missale G; Cariani E; Ferrari C
Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
[TBL] [Abstract][Full Text] [Related]
17. Chimpanzees in hepatitis C virus research: 1998-2007.
Bettauer RH
J Med Primatol; 2010 Feb; 39(1):9-23. PubMed ID: 19900169
[TBL] [Abstract][Full Text] [Related]
18. Host response to hepatitis C virus.
Mihm S
Hepatology; 2005 Mar; 41(3):679. PubMed ID: 15723317
[No Abstract] [Full Text] [Related]
19. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
[TBL] [Abstract][Full Text] [Related]
20. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
